WallStreetZenWallStreetZen

NASDAQ: BCTX
Briacell Therapeutics Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Briacell Therapeutics earnings were -$29.1M for the trailing 12 months ending Oct 31, 2025, with N/A growth year over year. The latest BCTX earnings report on Oct 31, 2025 announced Q4 2025 earnings of -$8.3M, down 0.7% from last quarter. For the last reported fiscal year 2025 ending Jul 31, 2025, BCTX reported annual earnings of -$26.6M, with 438.5% growth.

BCTX earnings history

Current Revenue
$0.0
Current Earnings
-$29.1M
Current Profit Margin
0%

BCTX Return on Equity

Current Company
-277.9%
Current Industry
-21.3%
Current Market
35.2%
BCTX's Return on Equity (-277.9%)... subscribe to Premium to read more.
High Return on Equity Performance

BCTX undefined

Current Company
-190.4%
Current Industry
-8.8%
BCTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BCTX announces earnings.

BCTX undefined

Current Company
-299.07%
Current Industry
-3.4%
BCTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BCTX-$29.07M-$29.08MN/A-$39.24
APVO-$26.24M-$27.95M-98.47%$1,860.37
GDTC-$2.58M-$2.87MN/A-$0.25
CASIN/A-$49.38MN/A-$3.01
CTXR-$38.95M-$40.99MN/A-$5.09
View Top Biotech Stocks

Briacell Therapeutics Earnings Reports & History FAQ

What were Briacell Therapeutics's earnings last quarter?

Briacell Therapeutics (NASDAQ: BCTX) reported Q3 2025 earnings per share (EPS) of -$4.35, up 86.69% year over year. Total BCTX earnings for the quarter were -$8.28 million. In the same quarter last year, Briacell Therapeutics's earnings per share (EPS) was -$32.67.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.

Is Briacell Therapeutics profitable or losing money?

As of the last Briacell Therapeutics earnings report, Briacell Therapeutics is currently losing money. Briacell Therapeutics's net profit (also called net income) for the twelve months ending Oct 31, 2025 was -$29.08 million, a 73.07% increase year over year.

What was BCTX's earnings growth in the past year?

As of Briacell Therapeutics's earnings date in Q4 2025, Briacell Therapeutics's earnings has grown year over year. BCTX earnings in the past year totalled -$29.08 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.